Q1 2025 · 13F-HR
Sio Capital Management, LLCholdings as filed
Filed 2025-05-15 · accession 0001214659-25-007756
$335.8M
Reported value
54
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G4705A100 | ICLR | ICON PLC | $35.6M | 10.6% | 203,311 | Common | SOLE |
| 577933104 | MMS | MAXIMUS INC | $31.9M | 9.51% | 468,352 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $24.3M | 7.23% | 270,596 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $21.2M | 6.33% | 187,685 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $20.7M | 6.18% | 187,573 | Common | SOLE |
| 504922105 | LH | LABCORP HOLDINGS INC | $19.5M | 5.81% | 83,873 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $18.3M | 5.45% | 507,562 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $15.2M | 4.51% | 207,000 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $14.9M | 4.44% | 107,780 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $14.1M | 4.21% | 1,107,613 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $10.0M | 2.97% | 141,134 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $8.6M | 2.57% | 2,369,960 | Common | SOLE |
| 405024100 | HAE | HAEMONETICS CORP MASS | $8.5M | 2.54% | 133,966 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $6.6M | 1.95% | 3,397,786 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $6.5M | 1.92% | 1,514,300 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $5.8M | 1.74% | 87,298 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $5.6M | 1.67% | 78,300 | PUT | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $4.6M | 1.36% | 788,670 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES INC I | $4.3M | 1.27% | 112,500 | Common | SOLE |
| 05350V106 | AVNS | AVANOS MED INC | $4.1M | 1.22% | 285,989 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $4.1M | 1.21% | 3,735,396 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $3.9M | 1.15% | 416,617 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $3.6M | 1.09% | 73,511 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $3.6M | 1.08% | 500,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $3.4M | 1.02% | 85,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $3.1M | 0.91% | 473,607 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $3.0M | 0.89% | 121,178 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $3.0M | 0.88% | 2,582,655 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $2.7M | 0.81% | 2,054,593 | Common | SOLE |
| 92243A200 | VXRT | VAXART INC | $2.3M | 0.68% | 5,583,448 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $2.2M | 0.65% | 121,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $2.1M | 0.63% | 116,997 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2.0M | 0.60% | 123,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $2.0M | 0.59% | 719,654 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $1.9M | 0.55% | 1,356,186 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.7M | 0.50% | 315,105 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $1.5M | 0.45% | 1,017,616 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $1.5M | 0.44% | 180,720 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $1.1M | 0.34% | 391,629 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.0M | 0.31% | 837,159 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $977,062 | 0.29% | 177,004 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $812,951 | 0.24% | 1,328,352 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $768,600 | 0.23% | 630,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $696,161 | 0.21% | 2,232,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $572,379 | 0.17% | 71,458 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $564,270 | 0.17% | 276,603 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC. | $444,103 | 0.13% | 121,672 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $354,856 | 0.11% | 50,839 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $274,669 | 0.08% | 251,990 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $244,708 | 0.07% | 162,058 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $62,439 | 0.02% | 130,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $27,600 | 0.01% | 10,000 | Common | SOLE |
| 44486Q111 | HUMAW | HUMACYTE INC | $18,124 | 0.01% | 49,998 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $17,120 | 0.01% | 400,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.